No black box warning on record for Tachosil

As of the latest FDA labeling reviewed, Tachosil (THROMBIN HUMAN AND FIBRINOGEN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tachosil medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Thrombosis can occur if TachoSil is applied intravascularly. Ensure that TachoSil is applied to the surface of cardiac, vascular or hepatic tissue only. ( 5.1 ) • Can cause hypersensitivity or allergic/anaphylactoid reactions with first time or repetitive application. ( 5.2 ) • Avoid use in contaminated areas of the body or in the presence of an active infection. ( 5.3

No black box warning on record for Tachosil

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Thrombosis can occur if TachoSil is applied intravascularly. Ensure that TachoSil is applied to the surface of cardiac, vascular or hepatic tissue only. ( 5.1 ) • Can cause hypersensitivity or allergic/anaphylactoid reactions with first time or repetitive application. ( 5.2 ) • Avoid use in contaminated areas of the body or in the presence of an active infection. ( 5.3

Tachosil Black Box Warning

No black box warning on record for Tachosil

Other warnings & precautions

Tachosil Black Box Warning

No black box warning on record for Tachosil

Other warnings & precautions